High plasma retinol binding protein-4 and low plasma adiponectin concentrations are associated with severity of glucose intolerance in women with previous gestational diabetes mellitus

Journal of Clinical Endocrinology and Metabolism

Volumn 93, Issue 8, 2008, Pages 3142-3148

  Sung, Hee Choi ^a,b   Soo, Heon Kwak ^c   Youn, Byung Soo ^d,e   Lim, Soo ^a   Young, Joo Park ^a,b   Lee, Hyewon ^d   Lee, Namseok ^d   Young, Min Cho ^b,c   Hong, Kyu Lee ^b,c   Kim, Young Bum ^f   Kyong, Soo Park ^b,c   Jang, Hak C ^a,b  

^a Seoul National University Bundang Hospital   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

^c Seoul National University Hospital   (South Korea)

^d Korea University   (South Korea)

^e University of Ulsan   (South Korea)

^f HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; GLUCOSE; INSULIN; LEPTIN; PREALBUMIN; RESISTIN; RETINOL BINDING PROTEIN 4; TRIACYLGLYCEROL;

ABDOMINAL FAT; ADULT; ARTICLE; BLOOD PRESSURE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE MODEL; DISEASE SEVERITY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; METABOLIC PARAMETERS; NON INSULIN DEPENDENT DIABETES MELLITUS; PREGNANCY; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STATISTICAL SIGNIFICANCE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 49249135177     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2007-1755     Document Type: Article

References (42)

1. Metzger BE, Coustan DR 1998 Summary and recommendations of the Fourth International Workshop-Conference on Gestational Diabetes Mellitus. The Organizing Committee. Diabetes Care 21(Suppl 2):B161-B167
2. Di Cianni G, Miccoli R, Volpe L, Lencioni C, Del Prato S 2003 Intermediate metabolism in normal pregnancy and in gestational diabetes. Diabetes Metab Res Rev 19:259-270
3. Metzger BE, Bybee DE, Freinkel N, Phelps RL, Radvany RM, Vaisrub N 1985 Gestational diabetes mellitus. Correlations between the phenotypic and genotypic characteristics of the mother and abnormal glucose tolerance during the first year postpartum. Diabetes 34(Suppl 2):111-115
4. Kjos S, Peters R, Xiang A, Henry O, Montoro M, Buchanan T 1995 Predicting future diabetes in Latino women with gestational diabetes. Diabetes 44:586-591
5. Kim C, Newton KM, Knopp RH 2002 Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care 25:1862-1868
6. Cho NH, Jang HC, Park HK, Cho YW 2006 Waist circumference is the key risk factor for diabetes in Korean women with history of gestational diabetes. Diabetes Res Clin Pract 71:177-183
7. Cho NH, Lim S, Jang HC, Park HK, Metzger BE 2005 Elevated homocysteine as a risk factor for the development of diabetes in women with a previous history of gestational diabetes mellitus: a 4-year prospective study. Diabetes Care 28:2750-2755
8. Jang HC, Yim CH, Han KO, Yoon HK, Han IK, Kim MY, Yang JH, Cho NH 2003 Gestational diabetes mellitus in Korea: prevalence and prediction of glucose intolerance at early postpartum. Diabetes Res Clin Pract 61:117-124
9. Metzger BE, Cho NH, Roston SM, Radvany R 1993 Prepregnancy weight and antepartum insulin secretion predict glucose tolerance five years after gestational diabetes mellitus. Diabetes Care 12:1598-1605
10. Kershaw EE, Flier JS 2004 Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 89:2548-2556
11. Shepherd PR, Gnudi L, Tozzo E, Yang H, Leach F, Kahn BB 1993 Adipose cell hyperplasia and enhanced glucose disposal in transgenic mice overexpressing GLUT4 selectively in adipose tissue. J Biol Chem 268:22243-22246
12. Abel ED, Peroni O, Kim JK, Kim YB, Boss O, Hadro E, Minnemann T, Shulman GI, Kahn BB 2001 Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver. Nature 409:729-733
13. Quadro L, Blaner WS, Salchow DJ, Vogel S, Piantedosi R, Gouras P, Freeman S, Cosma MP, Colantuoni V, Gottesman ME 1999 Impaired retinal function and vitamin A availability in mice lacking retinol-binding protein. EMBO J 18:4633-4644
14. Yang Q, Graham TE, Mody N, Preitner F, Peroni OD, Zabolotny JM, Kotani K, Quadro L, Kahn BB 2005 Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 436:356-362
15. Graham TE, Yang Q, Bluher M, Hammarstedt A, Ciaraldi TP, Henry RR, Wason CJ, Oberbach A, Jansson PA, Smith U, Kahn BB 2006 Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N Engl J Med 354:2552-2563
16. Cho YM, Youn BS, Lee H, Lee N, Min SS, Kwak SH, Lee HK, Park KS 2006 Plasma retinol-binding protein-4 concentrations are elevated in human subjects with impaired glucose tolerance and type 2 diabetes. Diabetes Care 29:2457-2461
17. Balagopal P, Graham TE, Kahn BB, Altomare A, Funanage V, George D 2007 Reduction of retinol binding protein (RBP4) in obese children by lifestyle intervention: association with sub-clinical inflammation. J Clin Endocrinol Metab 92:1971-1974
18. Gavi S, Stuart LM, Kelly P, Melendez MM, Mynarcik DC, Gelato MC, McNurlan M 2007 Retinol binding protein 4 is associated with insulin resistance and body fat distribution in non-obese subjects without type 2 diabetes. J Clin Endocrinol Metab 92:1886-1890
19. Janke J, Engeli S, Boschmann M, Adams F, Bohnke J, Luft FC, Sharma AM, Jordan J 2006 Retinol-binding protein 4 in human obesity. Diabetes 55:2805-2810
20. Erikstrup C, Mortensen OH, Perdersen BK 2006 Retinol-binding protein 4 and insulin resistance. N Engl J Med 355:1393-1394; author reply 1394-1395
21. Vitkova M, Klimcakova E, Kovacikova M, Valle C, Moro C, Polak J, Hanacek J, Capel F, Viguerie N, Richterova B, Bajzova M, Hejnova J, Stich V, Langin D 2007 Plasma levels and adipose tissue mRNA expression of retinol-binding protein 4 are reduced during calorie restriction in obese subjects but are not related to diet-induced changes in insulin sensitivity. J Clin Endocrinol Metab 92:2330-2335
22. Raila J, Henze A, Spranger J, Mohlig M, Pfeiffer AFH, Schweigert FJ 2007 Microalbuminuria is a major determinant of elevated plasma retinol-binding protein 4 in type 2 diabetic patients. Kidney Int 72:505-511
23. Hotta K, Funahashi T, Bodkin NL, Ortmeyer HK, Arita Y, Hansen BC, Matsuzawa Y 2001 Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys. Diabetes 50:1126-1133
24. Pellme F, Smith U, Funahashi T, Matsuzawa Y, Brekke H, Wiklund O, Taskinen MR, Jansson PA 2003 Circulating adiponectin levels are reduced in nonobese but insulin-resistant first-degree relatives of type 2 diabetic patients. Diabetes 52:1182-1186
25. Winzer C, Wagner O, Festa A, Schneider B, Roden M, Bancher-Todesca D, Pacini G, Funahashi T, Kautzky-Willer A 2004 Plasma adiponectin, insulin sensitivity, and subclinical inflammation in women with prior gestational diabetes mellitus. Diabetes Care 27:1721-1727
26. Jang HC, Cho NH, Min YK, Han IK, Jung KB, Metzger BE 1997 Increased macrosomia and perinatal morbidity independent of maternal obesity and advanced age in Korean women with GDM. Diabetes Care 20:1582-1588
27. Metzger BE 1991 Summary and recommendations of the Third International Workshop-Conference on gestation diabetes mellitus. Diabetes 40:197-201
28. The Expert Committee on the Diagnosis of Diabetes Mellitus 1997 Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20:1183-1197
29. Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults 2001 Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 285:2486-2497
30. Friedewald WT, Levy RI, Fredrickson DS 1972 Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 19:499-502
31. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC 1985 Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419
32. Vache C, Rousset P, Gachon P, Gachon AM, Morio B, Boulier A, Coudert J, Beaufrere B, Ritz P 1998 Bioelectrical impedance analysis measurements of total body water and extracellular water in healthy elderly subjects. Int J Obes Relat Metab Disord 22:537-543
33. Kautzky-Willer A, Prager R, Waldhausl W, Pacini G, Thomaseth K, Wagner OF, Ulm M, Streli C, Ludvik B 1997 Pronounced insulin resistance and inadequate β-cell secretion characterize lean gestational diabetes during and after pregnancy. Diabetes Care 20:1717-1723
34. Chan TF, Chen HS, Chen YC, Lee CH, Chou FH, Chen IJ, Chen SY, Jong SB, Tsai EM 2007 Increased serum retinol-binding protein 4 concentrations in women with gestational diabetes mellitus. Reprod Sci 14:169-174
35. Monaco HL 2000 The transthyretin-retinol-binding protein complex. Biochim Biophys Acta 1482:65-72
36. Kloting N, Graham TE, Berndt J, Kralisch S, Kovacs P, Wason CJ, Fasshauer M, Schon MR, Stumvoll M, Bluher M, Kahn BB 2007 Serum retinol-binding protein is more highly expressed in visceral than in subcutaneous adipose tissue and is a marker of intra-abdominal fat mass. Cell Metab 6:79-87
37. Qi Q, Yu Z, Ye X, Zhao F, Huang P, Hu FB, Franco OH, Wang J, Li H, Liu H, Lin X 2007 Elevated retinol-binding protein 4 levels are associated with metabolic syndrome in Chinese people. J Clin Endocrinol Metab 92:4827-4834
38. Takebayashi K, Suetsugu M, Wakabayashi S, Aso Y, Inukai T 2007 Retinol binding protein-4 levels and clinical features of type 2 diabetes mellitus. J Clin Endocrinol Metab 92:2712-2719
39. Koistinen HA, Remitz A, Gylling H, Miettinen TA, Koivisto VA, Ebeling P 2001 Dyslipidemia and reversible decrease in insulin sensitivity induced by therapy with 13-cis-retinoic acid. Diabetes Metab Res Rev 17:391-395
40. Rodondi N, Darioli R, Ramelet AA, Hohl D, Lenain V, Perdrix J, Wietlisbach V, Riesen WF, Walther T, Medinger L, Nicod P, Desvergne B, Mooser V 2002 High risk for hyperlipidemia and the metabolic syndrome after an episode of hypertriglyceridemia during 13-cis retinoic acid therapy for acne: a pharmacogenetic study. Ann Intern Med 136:582-589
41. Takashima N, Tomoike H, Iwai N 2006 Retinol-binding protein 4 and insulin resistance. N Engl J Med 355:1392; author reply 1394-1395
42. Stefan N, Hennige AM, Staiger H, Machann J, Schick F, Schleicher E, Fritsche A 2007 High circulation retinol binding protein 4 is associated with elevated liver fat, but not with total-, subcutaneous-, visceral-, or intramyocellular fat in humans. Diabetes Care 30:1173-1178